New and revised draft texts available for comment
Published 16 January 2025
As part of continued work to ensure the British Pharmacopoeia (BP) is up to date and relevant, we routinely upload new and revised draft texts for public consultation and feedback.
It is important to us that you, a user of the BP, have the chance to offer your views on these draft texts before they become a legal standard.
This public consultation period contains 20 draft texts.
5 new monographs for:
• Fludarabine for Injection |
• Fludarabine Sterile Concentrate |
• Ibuprofen Injection |
• Latanoprost Eye Drops |
• Trazodone Oral Solution |
15 revised monographs:
• Bumetanide Oral Solution | • Olmesartan Tablets |
• Compound Podophyllin Paint | • Podophyllum Resin |
• Desmopressin Injection | • Propranolol Prolonged-release Capsules |
• Desmopressin Intranasal Solution | • Propranolol Tablets |
• Desmopressin Nasal Spray | • Pyridostigmine Tablets |
• Desmopressin Oral Lyophilisate | • Trazodone Capsules |
• Desmopressin Tablets | • Trazodone Tablets |
• Ibuprofen Gel |
Submitting your views
All draft texts are listed on our site with specific instructions about how to submit your comments. The deadline for this round is 31 March 2025.
Thank you for your valuable contribution to this process.